Twist Bioscience (TWST) Accounts Payables (2018 - 2026)

Twist Bioscience (TWST) has reported Accounts Payables for 9 consecutive years, with $17.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables rose 42.2% year-over-year to $17.0 million in Q2 2026; TTM through Jun 2026 was $17.0 million, a 42.2% increase from a year earlier, with the FY2025 full-year figure at $11.1 million, up 580.61% from the prior year.
• Accounts Payables was $17.0 million for Q2 2026 at Twist Bioscience, up from $14.7 million in the prior quarter.
• Over five years, Accounts Payables peaked at $21.0 million in Q2 2022 and troughed at $1.6 million in Q3 2024.
• A 5-year average of $12.5 million and a median of $12.3 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 88.4% in 2024 and jumped 580.61% in 2025, its largest moves.
• Over 5 years, Accounts Payables stood at $20.1 million in 2022, then sank by 53.98% to $9.3 million in 2023, then declined by 18.94% to $7.5 million in 2024, then soared by 66.51% to $12.5 million in 2025, then soared by 36.42% to $17.0 million in 2026.
• The last three Accounts Payables figures came in at $17.0 million (Q2 2026), $14.7 million (Q1 2026), and $12.5 million (Q4 2025), per Business Quant data.